Dashboard
Portfolios
Watchlist
Community
Discover
Screener
KA
kapirey
Community Contributor
Followers
155
Total number of followers
Comments
8
Total number of comments
Member Since
2023
Date joined
Financial investor - International financial analyst - Family Office
No link added
MERLIN Properties SOCIMI
KA
kapirey
Community Contributor
Merlin Properties Will Embrace the Digital Age with Data Center Expansion
Merlin Properties: A Strategic Pivot Toward the Digital Future In 2025, Merlin Properties, one of the Iberian Peninsula’s leading real estate investment trusts (REITs), is undergoing a transformative phase. Traditionally known for its robust portfolio of offices, logistics centers, and shopping malls, Merlin has now set its sights on the digital frontier: data centers.
View narrative
€9.07
FV
20.4% overvalued
intrinsic discount
10.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 1 month ago
author updated this narrative
Scandinavian Tobacco Group
KA
kapirey
Community Contributor
Challenging Future for STG as Organic Sales Decline by 8.8%
Key Financial Results (Q1 2025) Reported net sales : DKK 2.0 billion ( +1.3% year-over-year ). Organic net sales growth : -8.8% , due to: Lower consumption of handmade cigars in the U.S. End of online distribution of ZYN in the U.S. Temporary supply issues caused by SAP implementation in European factories.
View narrative
DKK 116.13
FV
26.1% undervalued
intrinsic discount
2.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
27 days ago
author updated this narrative
4481
Base
KA
kapirey
Community Contributor
Goals for 2025 Profit attributable to owners of parent 11.5%
How does Base make money? Base offers software implementation and generation services, they are specialized in SAP.
View narrative
JP¥3.78k
FV
10.5% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 months ago
author updated this narrative
Atour Lifestyle Holdings
KA
kapirey
Community Contributor
For the full year of 2025, the Company currently expects total net revenues to increase by 25%
How does Atour make money? Atour is a hotel management company, mainly with its own hotels, as it seeks greater efficiency by reducing the number of rented hotels (only 32 as of December 2024).
View narrative
US$32.78
FV
6.4% undervalued
intrinsic discount
21.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 months ago
author updated this narrative
Evolution
KA
kapirey
Community Contributor
Evolution to Navigate Market Risks with Strategic Growth Initiatives
Risks Financial risk management: market risk (including currency risk and cash flow interest risk), credit risk and liquidity risk. Political decisions and other legal aspects.
View narrative
SEK 730.78
FV
4.4% undervalued
intrinsic discount
18.59%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
2
users have commented on this narrative
21
users have followed this narrative
about 1 month ago
author updated this narrative
Neurocrine Biosciences
KA
kapirey
Community Contributor
Neurocrine Biosciences revenue will grow by 10% with Crenessity and Ingrezza sales if they can maintain the retail price.
Catalysts Pipeline Crenessity@ CRENESSITY Capsule 50/100 MG $766.66 packaging 50 MG 60u $45,999.60 packaging 100 MG 30u $22,999.80 Ingrezza@ Ingrezza (valbenazine) costs approximately $7,921 for 28 capsules of the 40mg strength and $8,702 for 28 capsules of the 80mg strength. INGREZZA Capsule 40 MG $310.80 INGREZZA SPRINKLE Capsule 40 MG $310.80 Other Products: Tetrabenazine Tablet 12.5 MG $62.52 Austedo Tablet 6 MG $100.06 Austedo XR Tablet 6 MG $100.06 Xenazine Tablet 12.5 MG $227.88 Assumptions Risks Risks and uncertainties associated with Neurocrine Biosciences' business and finances in general, risks and uncertainties associated with the commercialization of INGREZZA and CRENESSITY.
View narrative
US$153.97
FV
17.8% undervalued
intrinsic discount
10.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
3 months ago
author updated this narrative
Cosmo Pharmaceuticals
KA
kapirey
Community Contributor
Cosmo Pharmaceuticals Announces Strong Full Year 2024 Revenue and Cash and Provides Business and Pipeline Updates
Catalysts Preliminary Unaudited Revenue and Cash Revenue: €266.8 million, representing a year-on-year increase of 188% compared to €92.8 million in 2023. This includes significant project-based revenues from GI Genius™ and Winlevi® of €190.2 million.
View narrative
CHF 87.47
FV
36.2% undervalued
intrinsic discount
11.00%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
0
users have commented on this narrative
82
users have followed this narrative
4 months ago
author updated this narrative
Tencent Holdings
KA
kapirey
Community Contributor
Tencent Holdings will see revenue grow by 14%
Market (what, how and where Tencent sells) Business (how much Tencent earn) Catalysts. How Tencent make more money in the next 5 years Weixin Video Accounts, Mini Games and Weixin Search enhance user value by creating seamless connections with products, services and content while presenting exciting revenue opportunities.
View narrative
HK$547.07
FV
7.6% undervalued
intrinsic discount
12.79%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
19
users have followed this narrative
4 months ago
author updated this narrative
Laboratorios Farmaceuticos Rovi
KA
kapirey
Community Contributor
Correcció del valor en l'horitzó 2024-25, creixement del valor a 10 anys vista
Per finals de 2024 l'empresa preveu -10% de resultat net, actualment es del 19%, així que estimo que quedaria al voltant del 10% Els ingresos de la vacuna de la covid de Moderna han desaparegut, pel que els ingressos disminuiràn esta construint una nova fabrica de fabricació a tercers VA haver rumor al 1r trimestre de negociacions per vendre les fabriques a tercers. Prevec que aquest 2024 i possiblement 2025 seran anys de decreixement degut al temps de maduració de les inversions en producció i l'apertura de nous mercats.
View narrative
€59.55
FV
7.6% undervalued
intrinsic discount
5.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
10 months ago
author updated this narrative
Grupo Catalana Occidente
KA
kapirey
Community Contributor
Grupo Catalana Occidente will expand in 2024 with bold acquisitions in Spain and Portugal
Catalysts GCO has 3 lines of business: Occidente dedicated to traditional life non-life and multi-risk insurance, Atradiu s dedicated to commercial credit and Mémora its funeral business line. Mémora continues with its strategy of inorganic growth through acquisitions of local companies in the Iberian Peninsula.
View narrative
€44.88
FV
9.4% overvalued
intrinsic discount
4.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
4 months ago
author updated this narrative
Banco Santander
KA
kapirey
Community Contributor
Banco Santander is not finding its place in online banking
Catalysts Banco Santander is present in Europe (Germany, Austria, Belgium, Denmark, Spain, Finland, Isle of Man, Italy, Norway, Poland, Portugal and the UK); North America (USA, Mexico); South America (Argentina, Brazil, Chile, Uruguay) Active customer base: 103 million. ONE Transformatio Project: transformation to an integrated digital model for all markets.
View narrative
€4.43
FV
56.1% overvalued
intrinsic discount
5.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
4 months ago
author updated this narrative
Intel
KA
kapirey
Community Contributor
Made in America is safer and better
La meva anterior narrativa es basava en: Intel va perdre la possibilitat de dissenyar el xip de la futura PlayStation 6. L'empresa ha diversificat el seu negoci i la seva estratègia des de fa uns anys, però recentment va perdre aquesta oportunitat clau.
View narrative
US$22.32
FV
5.6% undervalued
intrinsic discount
2.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 months ago
author updated this narrative